Quick Answer
MYRIAD GENETICS INC reported Long Term Debt of $119.90 million for the year ending 2025.
- MYRIAD GENETICS INC showed an increase of +202.8% in Long Term Debt from 2024 to 2025.
- This data is from MYRIAD GENETICS INC's annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2017 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2016: $204.00 million | Q1 2017: $167.10 million | Q3 2017: $74.20 million | Q4 2017: $43.20 million | Q1 2018: $69.30 million | Q3 2018: $258.00 million | Q4 2018: $273.30 million | Q1 2019: $263.40 million | Q3 2019: $225.00 million | Q4 2019: $225.10 million | Q1 2020: $225.20 million | Q2 2020: $224.40 million | Q3 2020: $224.60 million | Q4 2020: $224.80 million | Q1 2021: $154.00 million | Q2 2021: $0.00 | Q3 2021: $0.00 | Q2 2023: $38.40 million | Q3 2023: $38.50 million | Q1 2024: $38.70 million | Q2 2024: $38.80 million | Q3 2024: $39.00 million | Q1 2025: $59.30 million | Q2 2025: $0.00 | Q3 2025: $119.50 million.
- Over the full 10 years of available data (2017 to 2025), MYRIAD GENETICS INC's Long Term Debt has grown by 21.0%.
- Historical annual values: Fiscal year 2025: $119.90 million | Fiscal year 2024: $39.60 million | Fiscal year 2023: $38.50 million | Fiscal year 2022: $0.00 | Fiscal year 2021: $0.00 | Fiscal year 2020: $224.80 million | Fiscal year 2020: $224.40 million | Fiscal year 2019: $233.50 million | Fiscal year 2018: $9.30 million | Fiscal year 2017: $99.10 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: